Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension

This publication has 24 references indexed in Scilit:

• Inhaled Nitric Oxide Therapy
  Mayo Clinic Proceedings, 1995
• Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
  New England Journal of Medicine, 1993
• Inhaled nitric oxide in congenital heart disease.
  Circulation, 1993
• Inhaled Nitric Oxide after Mitral Valve Replacement in Patients with Chronic Pulmonary Artery Hypertension
  Anesthesiology, 1992
• Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
  The Lancet, 1991
• Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
  Circulation Research, 1989
• Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids
  Toxicon, 1989
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
  Proceedings of the National Academy of Sciences, 1987
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
  Nature, 1987
• Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work.
  Circulation, 1985